Solid Tumors Clinical Trials in Portland, Oregon

4 studies are recruiting for solid tumors in Portland, Oregon right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

  1. Long-term Safety and Efficacy Extension Study for Participants With Advanced Tumors Who Are Currently on Treatment or in Follow-up in a Pembrolizumab (MK-3475) Study (MK-3475-587/KEYNOTE-587)

    The purpose of this study is to evaluate the long-term safety and efficacy of pembrolizumab (MK-3475) in participants from previous Merck pembrolizumab-based parent studies who transition into this extension study. This study will consist of three phases: 1) First Course Phase, 2) Survival Follow-u…

    Stage
    Phase 3
    Ages
    18 and older
    Site
    Providence Portland Medical Center ( Site 0051), Portland, Oregon
    Locations
    782 in total
    Run by
    Merck Sharp & Dohme LLC

    See if you can join NCT03486873 on ClinicalTrials.gov

  2. A Study to Evaluate Chemotherapy With or Without INCB161734 in Previously Untreated, KRAS G12D-Mutated Metastatic Pancreatic Ductal Adenocarcinoma

    The purpose of this study is to evaluate the efficacy and safety of standard chemotherapy with or without INCB161734 in participants with metastatic pancreatic ductal adenocarcinoma (PDAC).

    Stage
    Phase 3
    Ages
    18 and older
    Site
    Investigative Site US042, Portland, Oregon
    Locations
    229 in total
    Run by
    Incyte Corporation

    See if you can join NCT07522073 on ClinicalTrials.gov

  3. A Study to Evaluate the Safety,Tolerability, Pharmacokinetics and Clinical Activity of Mocertatug Rezetecan for Injection in Participants With Advanced Solid Tumors (BEHOLD-1)

    The goal of this study is to assess the safety and tolerability of Mocertatug Rezetecan . The study will also see how the levels of Mo-Rez change over time at different dose amount

    Stage
    Phase 1
    Ages
    18 and older
    Site
    GSK Investigational Site, Portland, Oregon
    Locations
    65 in total
    Run by
    GlaxoSmithKline

    See if you can join NCT06431594 on ClinicalTrials.gov

  4. DB-1311 in Combination With BNT327 or DB-1305 in Advanced/Metastatic Solid Tumors

    A Phase II, Multicenter, Open-Label Trial of DB-1311 in combination with BNT327 or DB-1305 in Participants with Advanced/Metastatic Solid Tumors

    Stage
    Phase 2
    Ages
    18 and older
    Site
    USA15-0, Portland, Oregon
    Locations
    37 in total
    Run by
    DualityBio Inc.

    See if you can join NCT06953089 on ClinicalTrials.gov

How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.

What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.

Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.